The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns for metastatic castration-resistant prostate cancer (mCRPC) in oncology (ONC) urology (URO) practices: Data from the PROCEED registry.
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; DAVAOncology; Endocyte; Mannkind; UpToDate
Consulting or Advisory Role - Amgen; AVEO; BIND Biosciences; Cerulean Pharma; Janssen Biotech; Labceutics; Pfizer
Speakers' Bureau - Bayer; Caris MPI; Dendreon; Genentech/Roche; GlaxoSmithKline; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Andrew J. Armstrong
Honoraria - Dendreon; Sanofi
Consulting or Advisory Role - Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Sanofi
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); ImClone Systems (Inst); Janssen Oncology (Inst); KangLaiTe (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Dendreon; Janssen Biotech; Medivation
 
Celestia S. Higano
Employment - Cell Therapeutics (I)
Leadership - Cell Therapeutics (I)
Stock and Other Ownership Interests - Cell Therapeutics (I)
Consulting or Advisory Role - AbbVie; Bayer; BHR Pharma; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Orion Corporation; Pfizer; Sanofi
Research Funding - Algeta/Bayer (Inst); Aragon Pharmaceuticals (Inst); AstraZeneca (Inst); Dendreon (Inst); Emergent BioSolutions (Inst); Exelixis (Inst); Genentech (Inst); Medivation (Inst); Millennium (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst)
Travel, Accommodations, Expenses - AbbVie; Amgen; Astellas Pharma; Bayer; Dendreon; Ferring; Genentech; Johnson & Johnson; Medivation; Ockham; Orion Pharma GmbH; Pfizer; Sanofi; Teva
 
A. Oliver Sartor
Consulting or Advisory Role - Algeta ASA; Aragon Pharmaceuticals; Astellas Pharma; Bavarian Nordic; Bayer; Bellicum Pharmaceuticals; Biscayne Pharmaceuticals; Johnson & Johnson; Medivation; Oncogenex; Pfizer; Sanofi
Research Funding - Algeta ASA (Inst); Bayer (Inst); Johnson & Johnson (Inst); Progenics (Inst); Sanofi (Inst); Takeda (Inst)
 
Christopher Michael Pieczonka
Stock and Other Ownership Interests - Augmenix
Honoraria - Astellas Pharma; Bayer
Consulting or Advisory Role - Bayer; Dendreon; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Dendreon; Janssen
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Dendreon (Inst); Janssen (Inst)
 
Raoul S. Concepcion
Consulting or Advisory Role - Algeta ASA; Bayer; Cardinal Health; Chan Soon-Shiong Institute for Advanced Health; Dendreon; MDxHealth
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Janssen; Medivation; Sanofi
Research Funding - BN ImmunoTherapeutics (Inst); Dendreon (Inst); Janssen (Inst); Medivation (Inst)
 
Ronald F. Tutrone
Stock and Other Ownership Interests - Nymox; Sophiris Bio
Honoraria - Nymox
Consulting or Advisory Role - Medivation/Astellas
Speakers' Bureau - Dendreon; Medivation/Astellas
Research Funding - Advaxis (Inst); American Medical Systems (Inst); Bayer (Inst); Boston Scientific (Inst); Genomic Health (Inst); Janssen Oncology (Inst); MDxHealth (Inst); Medivation/Astellas (Inst); Nymox (Inst); Sophiris Bio (Inst)
 
Carl A. Olsson
No Relationships to Disclose
 
James L. Bailen
Honoraria - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Consulting or Advisory Role - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Auxilium; Bayer; Dendreon; Janssen; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer; Dendreon (Inst); Janssen (Inst); Medivation (Inst); Millennium
Travel, Accommodations, Expenses - Astellas Pharma; Dendreon
 
David F. Penson
Consulting or Advisory Role - Astellas Pharma; Medivation
Research Funding - Astellas Pharma (Inst); Medivation (Inst)
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
 
Jennifer Susan LIll
Employment - Dendreon
Stock and Other Ownership Interests - Bristol-Myers Squibb; Valeant Pharmaceuticals International
 
Robert Claude Tyler
Employment - Dendreon; Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Matthew R. Cooperberg
Honoraria - Takeda
Consulting or Advisory Role - Astellas Pharma; Bayer; Dendreon; Janssen; Myriad Pharmaceuticals
Research Funding - GenomeDx (Inst); Genomic Health (Inst); Myriad Pharmaceuticals (Inst)